✦ LIBER ✦

Treatment of Hyperhomocysteinemia and Endothelial Dysfunction in Renal Transplant Recipients With B Vitamins in the Chinese Population

✍ Scribed by Tao, Xu; Xiao-wei, Zhang; Xing-ke, Qu; Hai-yun, Ye; Xiao-bo, Huang; Xiao-peng, Zhang; Shu-kun, Hou; Xiao-feng, Wang

Book ID: 123322354
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 101 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2007.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective treatment of hyperhomocysteine

Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure

✍ Richard C Cook; Stephen Parker; Kori Kingsbury; Jiri J Frohlich; James G Abel; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Early experience with sildenafil for the

Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients

✍ Barrou, B. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 91 KB

The association between MMF and risk of

The association between MMF and risk of progressive renal dysfunction and death in adult liver transplant recipients with HCV

✍ John Lake; Dharmesh Patel; Kristin David; Jason Richwine; Jonathan Morris 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Early Withdrawal of Calcineurin Inhibito

Early Withdrawal of Calcineurin Inhibitors and Rescue Immunosuppression with Sirolimus-Based Therapy in Renal Transplant Recipients with Moderate to Severe Renal Dysfunction

✍ R. K. Wali; V. Mohanlal; E. Ramos; S. Blahut; C. Drachenberg; J. Papadimitriou; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

Topical treatment of cutaneous Kaposi sa

Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation

✍ B. M. Prinz Vavricka; G. F. L. Hofbauer; R. Dummer; L. E. French; W. Kempf 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB